Automation is one of the most overhyped and underdelivered investments organizations make. The technology is real — but without the right strategy, organizations automate the wrong things, in the wrong order, and end up with a portfolio of tools that don't talk to each other and don't move the needle.
Automation strategy work starts with the business problem, not the technology. It identifies where automation creates genuine, measurable value — and builds a prioritized, implementable plan to capture it. Having led enterprise-scale automation agendas in complex, regulated environments, I know what works in practice, not just in pitch decks.
Not every process that can be automated should be. Here's how I think about separating high-value opportunities from expensive distractions.
We identify and evaluate automation candidates across your organization — scoring each by value potential, feasibility, and risk. The output is a prioritized opportunity inventory, not a wishlist.
We develop a sequenced automation roadmap — what to pursue first, what technology approach fits each use case, and what governance model is needed to sustain the program over time.
For organizations that need to secure investment, we build a rigorous business case — quantifying expected savings, implementation costs, and payback timeline in terms leadership and finance can act on.
If tool selection is part of the scope, we evaluate options against your specific requirements — not vendor marketing claims. We also establish the governance structure to manage, monitor, and evolve your automation portfolio.
Fix the process first. Automating a broken workflow just creates a faster broken workflow.
No vendor affiliations, no preferred tools. Recommendations are based on your needs, not what's easiest to sell.
Automation in life sciences, finance, and other regulated industries has real governance requirements. I've navigated them.
Let's take an honest look at where you are, what's working, and where the real opportunities are.